Journal article

Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation

Drug testing and analysis, 2010 Nov-Dec. Henninge J, Pepaj M, Hullstein I and 1 others.

Study type
Journal article
Subjects
Not classified in PubMed MeSH
Journal
Drug testing and analysis
Published
2010 Nov-Dec
PubMed
PMID 21204297 ↗
DOI
10.1002/dta.233 ↗

Where PepCue cites this

This paper is part of the evidence base behind this profile. Citing a study is not an endorsement of the compound: papers that found no effect are indexed the same way.

Mod-GRF (1-29) →

Indexed under

MeSH terms assigned by the National Library of Medicine.

Chromatography, LiquidGrowth Hormone-Releasing HormonePeptide FragmentsPerformance-Enhancing SubstancesPharmaceutical PreparationsTandem Mass Spectrometry

Other papers on Mod-GRF (1-29)

Randomized controlled trial · 2006
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults
Clinical trial · 2006
Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog
Journal article · 2009
Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects

PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page
Compounds